欧州における医薬品開発業務受託機関（CRO）市場

Abstract

Research Overview

This analysis is available through our Drug Discovery Technologies Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

To maximize the potential for growth within a firm's internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan's strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients' growth.

Table of Contents

• 1. Executive Summary
  • 1. Industry Snapshot
    • 1. Executive Summary
• 2. Exchange Rates and Glossary of Terms
  • 1. Glossary and Exchange Rates
    • 1. Glossary of Terms
    • 2. Exchange Rates
• 3. Industry Challenges
  • 1. Research Scope and Methodology
    • 1. Research Scope and Methodology
  • 2. Industry Challenges
    • 1. Industry Challenges
• 4. Market Engineering Research of the Contract Research Organisation Markets in Europe
  • 1. Forecasts for Contract Research Organisation Markets in Europe
    • 1. Introduction
    • 2. Market Overview
    • 3. Market Segmentation
    • 4. Market Engineering Measurements
  • 5. Market Drivers
    • a. Greater Financial Benefits Leading to Outsourcing Growth
    • b. More Expert Knowledge to Build a Strategic Fit
    • c. Greater R&D Productivity to Drive Growth
    • d. Continued Globalisation Fuels Demand for CRO Services
    • e. Clinical Trials Testing from Low Cost Countries and Large Pools of Untreated Patients
    • f. Reduced R&D Complexity and Opportunities to Focus on Core Competencies
    • 6. Market Restraints
    • a. Regulatory Hurdles Pose a Quality Challenge and Discourages Innovation
    • b. Security of Proprietary Knowledge Risks Management of Third-Party Relationships
    • c. Lack of Domain Expertise Limits Opportunities
    • d. The Breadth of Offerings and Quality of Service Vary Between CROs
    • e. Poor Process Design and Low Tolerance Errors
    • 7. Revenue Forecasts
    • 8. Competitive Structure
• 5. Work Outsourced to CROs Markets in Europe
  • 1. Market Engineering Measurements
    • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
    • 1. Revenue Forecast Analysis
• 6. Work Outsourced to Other Organisations Markets in Europe
  • 1. Market Engineering Measurements
    • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
    • 1. Revenue Forecast Analysis
• 7. Market Engineering Strategic Recommendations
  • 1. Market Engineering Strategic Recommendations
    • 1. Strategic Recommendations
• 8. Portfolio Analysis
  • 1. Company Profiles
    • 1. Charles River Laboratories International Inc.
    • 2. Covance Inc.
    • 3. ICON Plc.
    • 4. Kendle International Inc.
    • 5. MDS Pharma Services.
    • 6. Omincare Clinical Research Inc.
    • 7. PAREXEL International Corp.
    • 8. Pharmaceutical Product Development Inc.
    • 9. PharmaNet Inc.
    • 10. Quintiles Transnational Corp.
• 9. Decision Support Databases
  • 1. Decision Support Databases
    • 1. Decision Support Databases
• 10. Database of Key Industry Participants
  • 1. Key Industry Participants
    • 1. List of Key Industry Participants